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Background: Incisional hernias are one of the most frequent complications in abdominal surgery.
Laparoscopic repair has been widely used since its ﬁrst description but has not been standardized. A
panel of hernia experts with expertise on the subject “incisional hernia” was established to review
existing literature and deﬁne a standard approach to laparoscopic IPOM-repair for incisional hernia. All
involved surgeons agreed to perform further IPOM-repairs of incisional hernia according to the protocol.
Methods/design: This article summarizes the development of an open prospective observational multi-
centre cohort study to analyse the impact of a standardization of laparoscopic IPOM-repair for incisional
hernia on clinical outcome and quality of life (health care research study).
Discussion: Our literature search found that there is a lack of standardization in the surgical approach to
incisional hernia and the use of medical devices. The possibility of different surgical techniques, various
meshes and a variety of mesh ﬁxation techniques means that the results on outcome after incisional
hernia repair are often not comparable between different studies. We believe there is a need for stan-
dardization of the surgical procedure and the use of medical devices in order to make the results more
comparable and eliminate confounding factors in interpreting the results of surgical hernia repair. This
approach, in our view, will also illustrate the inﬂuence of the operative technique on the general quality
of surgical treatment of incisional hernias better than a “highly selective” study and will indicate the
“reality” of surgical treatment not only in specialist centres.
Trial registration: The LIPOM-trial is registered at www.clinicaltrials.gov, with identiﬁer: NCT02089958.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).l onlay mesh augmentation;
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Inc. This is an open access article u1. Background/introduction
Incisional hernia is a frequent complication following abdom-
inal surgery, with an expected occurrence rate of 15e20% of pro-
cedures performed in Germany [1]. Symptomatic incisional hernia
is typically treated by elective surgery [2]. In addition to the wide
variety of “traditionally” open surgical techniques for incisional
hernia repair, LeBlanc described in 1993 the technique of laparo-
scopic intraperitoneal onlay mesh repair (IPOM) [3]. However, a
standard protocol for the surgical technique of IPOM has nevernder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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bridging alone in terms of tensionless repair or in combinationwith
gap closure [4], the extent of mesh overlap covering the defect,
which varies from 3 to 5 cm and more, and mesh ﬁxation with a
stapler device alone, transfascial sutures alone or a combination of
these [5]. Furthermore, several study groups recommend a
maximum incisional hernia size of 5e10 cm (EHS W 1e2) as the
limit for IPOM because of unacceptable high rates of recurrence at
larger sizes [6e12]. Selection bias may also be related to the fact
that different surgeons perform laparoscopic IPOM without any
adjustment for surgeon-relatedmorbidity and the learning curve in
different patients who may present with various, often not speci-
ﬁed sizes of hernias and pre-morbid conditions [13]. A confounding
factor is also the lack of differentiation between “primary ventral
hernia” and “incisional hernia” along with the different medical
devices such as mesh implants and ﬁxation devices used in the
majority of published studies [4,14,15]. However, this heterogeneity
is still treated in the literature as “one surgical procedure for
comparable indications”, meaning that available results are not
completely comparable. Currently, it is impossible to provide
standard recommendations for the management of incisional her-
nias by laparoscopic IPOM [2,16].
The LIPOM-Trial (Laparoscopic Intraperitoneal Onlay Mesh
Augmentation) was designed to investigate the impact of a
consensus-driven standard protocol for both surgical technique
and use of medical devices in laparoscopic IPOM on clinical
outcome measures in a multicentre setting.
2. Methods/design
2.1. Study design
The LIPOM-trial is an open prospective multicentre cohort
study. According to the proposal of the IDEAL Framework for Sur-
gical Innovation the LIPOM-trial is an open prospective observa-
tional study at stage 2b (exploration), having a protocol that is
driven by standardized eligibility and prospective data collection
[17]. Health care outcome measures will be assessed in a consec-
utive cohort of patients with symptomatic incisional hernias, all of
whom will receive a laparoscopic IPOM based on a standard pro-
tocol as developed in a consensus process. To avoid inﬂuences due
to learning curve within the trial each surgeon is required to be
board-certiﬁed, to have experience of more than 20 laparoscopic
IPOM procedures and to have a yearly workload of more than 20
procedures. Inclusion criteria for participating centres and criteria
to minimize bias are a center-speciﬁc caseload of >20 procedures
per year, informed consent for the standard protocol, acceptance of
monitoring (the monitor is a member of the hernia panel), digital
imaging of each operation after adhesiolysis, outlining the hernia
size with intraabdominal ruler and following mesh positioning and
ﬁxation, an uncut video of each procedure, and data source veriﬁ-
cation with 100% electronic monitoring during the study and local
assessment by the monitor at the end of the study. The study
protocol has been approved by the Ethics Committee of each local
site, the Landes€arztekammer Hessen, the Landes€arztekammer
Nordrhein, and the Landes€arztekammer Schleswig.
2.2. Consensus process and development of a standard protocol
The structure of the consensus process was based on proposals
from the National Institute of Health. Five board-certiﬁed surgeons
with experience and readiness to be part in the development of a
data-based standard protocol for surgical technique and use of
medical devices in laparoscopic IPOM were included in the hernia
panel (HP). Relevant studies were identiﬁed in Medline, Embase,Cochrane Library, Cochrane controlled trials register, and Science
citation index (updated to May 2013) under the search terms
“abdominal wall hernia” or “ventral hernia” or “incisional hernia”,
and “laparoscopic” or “laparoscopy”, and “metaanalysis” or “ran-
domized controlled trial” or “RCT” or “observational trial” or “reg-
ister”, as well as by reviewing bibliographies from original research
articles and reviews.
In the ﬁrst step all HP members were asked in an interactive
workshop to describe their speciﬁc surgical technique in order to
identify possible variations in surgical technique and compile
common elements of a complete procedure. In the second step,
articles were reviewed for inclusion criteria as follows: “Incisional
hernia”, “type of mesh”, “ﬁxation technique”, “hernia size”, “mesh
overlap”, and “surgical technique”. Based on these data each of the
HP members was asked in a third step to propose a common step-
wise surgical procedure and use of medical products. Each
recommendation was discussed in a workshop. HP members ach-
ieved very high consensus (90%) with ﬁnal approval. The results
of this decision-making process were ﬁxed in a consensus docu-
ment containing the recommended standard procedure and se-
lection of medical devices (Table 1). Proof of concept and safety of
the underlying standardized technique and use of medical devices
was demonstrated in a prospective pilot study with 20 patients
enrolled (A. H., Fulda and G. P., Bamberg) without observation of
adverse events (AEs) and/or severe adverse events (SAEs).
2.3. Patients' inclusion/exclusion criteria
Patients will be consecutively enrolled in the study if they met
the following eligibility criteria: (1) age  18 years, (2) primary
incisional hernia, (3) symptomatic/progressive hernia, (4) hernia
size 10 cm (EHSW 1e2), and (5) hernia location according to EHS
of M 1e5 and L 1e3.
Patients will be excluded if they met any one of the following
criteria: (1) recurrent incisional hernia, (2) primary ventral hernia,
(3) hernia size > 10 cm (EHS W 3), (4) hernia location classiﬁed as
EHS L 4, (5) simultaneous surgical intervention, e.g. appendectomy,
(6) mesh overlap < 5 cm, (6) ASA score > 3, (7) malignant disease,
(8) liver cirrhosis, (9) peritoneal carcinosis, (10) lack of study
agreement, and (11) intraoperative lesion of the colon.
2.4. Data collection, objectives and endpoints
Research staff at the study sites will collect the data in an
organized electronic ongoing data collection program (Patient
Registry) according to the deﬁnition of the Agency for Healthcare
Research and Quality (AHRQ), (Fig. 1). Documentation will be
conducted via the web-based database “LIPOM” using an electronic
case report form (eCRF), ClinWise Version 1.0 (ClinWise Health-
Care, StatConsult, Germany). The number of patients lost to follow-
up will be recorded.
The primary outcome measure is the 1-year recurrence rate,
according to the recommendations for reporting outcome results in
abdominal wall repair (Results of a consensus meeting in Palermo,
Italy, 28e30 June 2012 [18]) as a time-to-event analysis for
“freedom-of-recurrence” as determined by physical examination
and ultrasound, or in the case of diagnostic failure of these tech-
niques, MRI or CT-scan.
Secondary outcome measures are perioperative complications
such as bleeding, haematoma, seroma, wound infection (classiﬁed
according to CDC A1e3), mesh infection, bowel injury, bowel ﬁs-
tula, reoperation, patient-reported pain (measured by Numeric
Rating Scale, NRS), patient-reported health-adapted quality of life
measured by California Comfort Scale (questionnaire translated
into German language; CCS [11]), and mortality.
Table 1
Summary of the consensus standard protocol for laparoscopic onlay mesh augmentation in incisional hernia repair.
General considerations
1. Use of a classiﬁcation to improve the possibility of comparing different populations/studies
2. Separation of the two entities “Ventral Hernia” and “Incisional Hernia”
3. Standardized operative technique (see surgical technique)
4. Standardized use of medical products (see surgical technique)
5. Technique of “bridging” is limited to hernia sizes up to a maximum of 10 cm
6. Technique of “gap closure” is limited to hernia sizes up to a maximum of 10 cm
7. Perform a Health Care Research Study
Surgical technique
1. Preoperative estimation of hernia classiﬁcation by physical examination and/or ultrasound and/or CT scan/MRI according to EHS guidelines
2. Access by mini-laparotomy or optical trocar
3. Capnoperitoneum up to 20 mmHg (see cardiac and respiratory function)
4. Three trocar technique, additional trocars to specify
5. Adhesiolysis/preparation of the spatium recii or the Lig. teres hepatis to insure mesh overlap of 5 cm
6. Resection of hernia sac (recommendation)
7. Measurement of hernia size/defect size under low pressure capnoperitoneum (8 mmgH) according to EHS guidelines
8. Calculating of mesh (Physiomesh™, CE marked) size with overlap of 5 cm (gap þ overlap)
9. Arming of mesh with one suture (nonabsorbable) each at the edges of the mesh (transfascial ﬁxation of mesh)
10. Alternative to “bridging”: “gap closure” with nonabsorbable sutures according to Chelala [4], calculation of mesh size as mentioned above
11. Positioning of the mesh in low pressure capnoperitoneum during ﬁxation (8 mmHg)
12. Transfascial ﬁxation of mesh with the four nonabsorbable sutures at the edges of the mesh (epifascial nodes, see 9.)
13. Fixation of mesh by SecureStrap™ (CE marked) in double crown technique (outer line: distance to the edges 0.5 cm, distance between tacs 2 cm, inner line: distance
1 cm to gap edge, distance between tacs 2 cm)
14. Transfascial closure of trocar incisions >5 mm
15. Standardized postoperative analgesia based on NRS, medication according to WHO scheme
Fig. 1. Data ﬂow chart.
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For statistical analysis personal datawill be pseudonymised, and
for publication the data will be anonymized. Data will be docu-
mented via web access (www.lipom-trial.de) in the database
“LIPOM” using an eCRF in ClinWise® Version 1.0 with automatic
pseudonymization of the patient's personal data. Access to the
database is limited to authentiﬁcation via user name and password
with free access limited to personal records. The database features a
reminder function regarding survey of follow up data and auto-
matically generates correspondence to the patient. Follow up of
NRS and CCS is patient-related. Data management including
documentation and analysis of follow up questionnaires and sta-
tistical analysis will be performed by StatConsult. Data safety is
guaranteed by StatConsult. ClinWise® is connected via an interface
to the Herniamed registry.2.6. Monitoring and statistical analysis
The following adverse events will be monitored: (1) wound
infection, (2) intraabdominal abscess, (3) mesh infection, (4) sepsis,
(5) intestinal or organ injury, (6) postoperative bleeding, (7)
pneumonia, (8) urinary tract infection, (9) deep vein thrombosis,
(10) bowel obstruction, (11) recurrent hernia, (12) vomiting, and
(13) pain at rest. Severe adverse events include (1) reoperation, (2)
ICU admission, (3) acute incarceration, (4) rehospitalization, and (5)
death. The principal investigator will be informed about SAEs
within 3 days. An independent Data Safety Management Board
(DSMB) consisting of two independent, external clinical experts
(Bernd Stechemesser; MD, PAN Klinik, K€oln, Germany, and Andreas
Koch, MD, FACS, Chirurgische Praxis, Cottbus, Germany) in hernia
surgery has been established to address patient safety and perform
risk-beneﬁt analysis. In accordance with its standard operativeTable 2
Time points for the collection of patient-reported and functional outcome data (AE, adverse event; SAE, severe adverse event; NRS, numeric rating scale; CCS, Carolina Comfort
Scale); *without questionnaire on mesh implant.
Criteria Time
1 d 0 1 2 3 4 5 Dis charge 6 wks 6 mth 12 mth
Patient's data x
Case history x
Comorbidity x
Physical exam/diagnostics x x x x x
Inclusion/exclusion criteria x
Preop discussion x
Informed consent x
Surgical data x
AEs/SAEs x x x x x x x x x x
NRS x x x x x x x x x x x
CCS X(*) x x x
Follow up questionnaire x x x
Follow up interview x x xprocedures, the DSMB reviews the incoming data to ensure
continued patient safety. The DSMB assesses study aspects such as
progress, integrity, and design and makes recommendations to the
study coordinator regarding modiﬁcation, continuation or termi-
nation of the study. The statistical analyses will be conducted by
StatConsult. The primary endpoint will be evaluated with the
Kaplan-Meier estimate and the related conﬁdence interval. For the
secondary endpoint “perioperative complications” rates andrelated conﬁdence intervals will be reported. Further descriptive
statistics will be reported for (quasi-)continuous variables (mean,
standard deviation, minimum, Q1, median, Q3, maximum) and
categorical variables (absolute and relative frequencies). Addition-
ally Box-Whisker-Plots will be presented for patient-reported pain
(NRS) and patient-reported health-adapted quality of life (CCS).2.7. Implementation of the study and trial status
All patients with incisional hernias presenting to the partici-
pating clinics will be screened for trial eligibility. After physical
examination and ultrasound examination (and if necessary CT or
MRI scan) the indication for an operationwill be determined. In the
case of an existing indication the inclusion and exclusion criteria
will be checked and informed consent will be obtained. The oper-
ative procedure will be performed according to the standard pro-
tocol as described above to allow a structured exploration with
comparable results.
All participating study sites have received a study synopsis and
signed a Declaration of Commitment. Hereby, all study centres have
agreed to act in strict accordance with the deﬁned surgical pro-
cedure, which has to be documented by an uncut video of each
procedure and observed by an authorizedmonitor. According to the
study protocol at least 100 patients will be included over 12
months. Primarymedical centres of different levels of health care as
well as university medical centres are involved in the LIPOM-Trial.
The time between the ﬁrst patient recruited and last patient treated
will be 24 months, which includes a recruitment period of 12
months and a follow up period of 12 months. Time points for the
collection of patient-reported and functional outcome data are
given in Table 2. The estimated duration of the entire study is 30
months including data analysis. The trial started in September 2013
with recruitment of the ﬁrst patients.3. Discussion
This article describes the development of an open prospective
observational multicentre cohort study analysing the inﬂuence of
a standard protocol for surgical technique and use of medical
devices for laparoscopic IPOM on clinical outcome and quality of
life. The standard protocol was developed on the basis of current
literature and the results of a stepwise consensus process
A. Hellinger et al. / Contemporary Clinical Trials Communications 4 (2016) 118e123122performed by a group of experienced surgeons. Our literature
search found that there is a lack of standardization in the surgical
approach to incisional hernia and the use of medical devices. The
possibility of different surgical techniques, various meshes and a
variety of mesh ﬁxation techniques means that the results on
outcome after incisional hernia repair are often not comparable
between different studies. Given these variations in parameters
and the individual differences in every hernia we believe there is a
need for standardization of the surgical procedure and the use of
medical devices in order to make the results more comparable and
eliminate confounding factors in interpreting the results of sur-
gical hernia repair. This approach, in our view, will also illustrate
the inﬂuence of the operative technique on the general quality of
surgical treatment of incisional hernias better than a “highly se-
lective” study and will indicate the “reality” of surgical treatment
not only in specialist centres.
4. Conclusion
The LIPOM-trial was designed to explore the impact of a strictly
deﬁned stepwise surgical technique for laparoscopic incisional
hernia repair on clinical outcome in order to reach a standard
recommendation for this procedure. To our opinion this stan-
dardization is a prerequisite to reduce surgical variation and
consequently improve the comparability of data.
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